Holen Sie sich die Stockscreener-App
71.56
1.97%
1.38
Handel nachbörslich:
72.41
0.85
+1.19%
Schlusskurs vom Vortag:
$70.18
Offen:
$70.2
24-Stunden-Volumen:
1.40M
Relative Volume:
1.20
Marktkapitalisierung:
$4.95B
Einnahmen:
$1.50B
Nettoeinkommen (Verlust:
$427.61M
KGV:
11.91
EPS:
6.01
Netto-Cashflow:
$423.98M
1W Leistung:
-13.85%
1M Leistung:
-9.64%
6M Leistung:
-23.91%
1J Leistung:
-38.73%
1-Tages-Spanne:
$69.93
$71.80
1-Wochen-Bereich:
$69.12
$83.32
52-Wochen-Spanne:
$69.12
$118.21
Lantheus Holdings Inc Stock (LNTH) Company Profile
Firmenname
Lantheus Holdings Inc
Sektor
Telefon
978 671-8001
Adresse
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Vergleichen Sie LNTH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
71.56 | 5.75B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
147.37 | 69.30B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 47.50B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.53 | 44.47B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.31 | 18.83B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
293.12 | 13.43B | 2.99B | 1.21B | 1.13B | 25.06 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-18 | Eingeleitet | Goldman | Buy |
| 2024-09-03 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-07-10 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-12-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Eingeleitet | TD Cowen | Outperform |
| 2023-09-29 | Eingeleitet | William Blair | Outperform |
| 2023-03-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-11-30 | Eingeleitet | SVB Leerink | Outperform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-05-09 | Eingeleitet | B. Riley Securities | Buy |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2021-02-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-29 | Fortgesetzt | Jefferies | Buy |
| 2019-08-16 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-09-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2016-02-24 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-12-11 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Eingeleitet | Credit Suisse | Outperform |
| 2015-07-20 | Eingeleitet | Jefferies | Buy |
| 2015-07-20 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-07-20 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-20 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten
What drives Lantheus Holdings Inc. stock priceFree Popular Stock Recommendations - Autocar Professional
Lantheus Holdings: Forget The Short Term Noise (NASDAQ:LNTH) - Seeking Alpha
Lantheus Holdings Inc. Stock Analysis and ForecastFree Stock Market Forecast Reports - PrintWeekIndia
What analysts say about Lantheus Holdings Inc. stockFree Trading Strategy Suggestions - jammulinksnews.com
Is Lantheus Holdings Inc. a good long term investmentOutstanding investment returns - jammulinksnews.com
Lantheus Holdings Inc Shares Down 3.19% Amidst Analyst Forecasts - AInvest
Lantheus (LNTH): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Lantheus sinks 8% as CMS wants to maintain reimbursement model for radiopharmaceuticals - MSN
Learn to Evaluate (LNTH) using the Charts - news.stocktradersdaily.com
Radiopharmaceutical Renaissance: Lantheus Navigates CMS Policy Shifts to Secure Dominance in Diagnostic Imaging - AInvest
Lantheus Holdings (LNTH) Plunges 14.94% Amid CMS Decision - AInvest
Lantheus Holdings (LNTH) Stock Falls as CMS Retains Current Reim - GuruFocus
Why Is Lantheus Stock Trading Lower On Wednesday? - Benzinga
Why Lantheus (LNTH) Stock Is Down Today - Yahoo Finance
Lantheus (LNTH) Shares Decline Amid Market Activity | LNTH Stock News - GuruFocus
Lantheus Plummets to 52-Week Low: Is the Bottom in Sight or More Pain Ahead? - AInvest
Lantheus Holdings stock reaches 52-week low at $72.92 By Investing.com - Investing.com South Africa
Lantheus Holdings stock reaches 52-week low at $72.92 - Investing.com
Lantheus (LNTH) Likely to Maintain Pylarify Reimbursement Status in 2026 | LNTH Stock News - GuruFocus
Lantheus (LNTH) Faces Setback with CMS Reimbursement Decision | - GuruFocus
Lantheus set to close $750M acquisition of PET agent developer Life Molecular Imaging - Radiology Business
Lantheus Holdings: Navigating Geopolitical Storms to Capture Precision Diagnostics Growth - AInvest
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know - Yahoo Finance
(LNTH) Investment Report - news.stocktradersdaily.com
Lantheus Holdings’ SWOT analysis: theranostics leader faces growth challenges - Investing.com
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2025 Earnings Call Transcript - MSN
Lantheus’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Could The Market Be Wrong About Lantheus Holdings, Inc. (NASDAQ:LNTH) Given Its Attractive Financial Prospects? - 富途牛牛
Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment - MSN
Riley Maintains ‘Buy’ Rating on Lantheus Holdings, Inc. (LNTH); Lowers PT - Insider Monkey
Lantheus Holdings (LNTH): A Breakthrough in Fibrosis Imaging and a Compelling Investment Thesis - AInvest
Lantheus to Present New Oncology Radiodiagnostic Data at SNMMI Meeting - MSN
Spotting Winners: Lantheus (NASDAQ:LNTH) And Medical Devices & SuppliesImaging, Diagnostics Stocks In Q1 - Yahoo Finance
Alzheimer’s Association Partners with Lantheus for 30th Annual Charity Golf Tournament - The Bedford Citizen
Lantheus at 2025 Truist Securities MedTech Conference: Strategic Growth Path - Investing.com Nigeria
Lantheus at 2025 Truist Securities MedTech Conference: Strategic Growth Path By Investing.com - Investing.com South Africa
(LNTH) Technical Data - news.stocktradersdaily.com
The total return for Lantheus Holdings (NASDAQ:LNTH) investors has risen faster than earnings growth over the last five years - simplywall.st
Lantheus Announces Presentations to be featured at the 2025 Soci - GuruFocus
Insider Sell: Julie Mchugh Sells Shares of Lantheus Holdings Inc (LNTH) - GuruFocus
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting - The Manila Times
Lantheus Holdings, Inc. to Present New Data on Oncology Radiodiagnostics at 2025 SNMMI Annual Meeting - Nasdaq
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and ... - Eagle-Tribune
Lantheus Unveils Breakthrough Cancer Diagnostic Results at SNMMI 2025: Multiple Studies Show Promise - Stock Titan
Lantheus at Goldman Sachs Conference: Strategic Expansion in Healthcare By Investing.com - Investing.com South Africa
Lantheus at Goldman Sachs Conference: Strategic Expansion in Healthcare - Investing.com
Transcript : Lantheus Holdings, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 02 - MarketScreener
Lantheus to Present at the 2025 Truist Securities MedTech Conference - The Manila Times
Lantheus CEO Reveals Growth Strategy: Key Insights Coming at Truist MedTech Conference - Stock Titan
Declining Stock and Solid Fundamentals: Is The Market Wrong About Lantheus Holdings, Inc. (NASDAQ:LNTH)? - Yahoo Finance
Finanzdaten der Lantheus Holdings Inc-Aktie (LNTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.68%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):